Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC
Jiangxi Provincial Cancer Hospital
Jiangxi Provincial Cancer Hospital
Asan Medical Center
SUNHO(China)BioPharmaceutical CO., Ltd.
Chinese PLA General Hospital
Shantou University Medical College
Institute of Oncology Ljubljana
Sun Yat-sen University
Fujian Cancer Hospital
Sun Yat-sen University
Sichuan University
Brigham and Women's Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Ruijin Hospital
First Affiliated Hospital of Guangxi Medical University
Qilu Pharmaceutical Co., Ltd.
Sun Yat-sen University
National Cancer Institute, Naples
Rutgers, The State University of New Jersey
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
CanariaBio Inc.
First Affiliated Hospital of Zhejiang University
Leiden University Medical Center
Sun Yat-sen University
Eye & ENT Hospital of Fudan University
Shanghai Henlius Biotech
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fudan University
First Affiliated Hospital Xi'an Jiaotong University
George Washington University
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Shanghai Hengrui Pharmaceutical Co., Ltd.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Samsung Medical Center
GOG Foundation
Peking Union Medical College Hospital
National Cancer Institute, Naples
National Cancer Institute, Naples
National Cancer Institute, Naples
The First Affiliated Hospital with Nanjing Medical University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Zhujiang Hospital
Zhujiang Hospital
China Three Gorges University, Yichang, China
Ain Shams University
Peking University Third Hospital
University of California, San Diego
Sun Yat-sen University